Comparison between Management and Pharmacotherapy of COVID-19 in Iran and Switzerland
Background: On 30 January 2020, the WHO declared the outbreak of SARS-CoV-2 as a public health emergency. In the present study, we compared the preventative and therapeutic strategies and the success rates of Iran and Switzerland during the COVID-19 outbreak. Materials and Methods: This study was co...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shahid Beheshti University of Medical Sciences
2022-12-01
|
| Series: | Novelty in Biomedicine |
| Subjects: | |
| Online Access: | https://journals.sbmu.ac.ir/nbm/article/view/38215 |
| _version_ | 1797846236515008512 |
|---|---|
| author | Payam Peymani Somaye Bazdar Leila Zarei Mehdi Hoorang Nazafarin Hatami-Mazinani Kamran B Lankarani Ali Reza Salili Fatemeh Dehghani Farshad Bargrizaneh Sara Moghaddam Maryam Matouri Shima Jafari Seyyed Amirreza Saghi Hamed Delam Motahareh Mahi-Birjand |
| author_facet | Payam Peymani Somaye Bazdar Leila Zarei Mehdi Hoorang Nazafarin Hatami-Mazinani Kamran B Lankarani Ali Reza Salili Fatemeh Dehghani Farshad Bargrizaneh Sara Moghaddam Maryam Matouri Shima Jafari Seyyed Amirreza Saghi Hamed Delam Motahareh Mahi-Birjand |
| author_sort | Payam Peymani |
| collection | DOAJ |
| description | Background: On 30 January 2020, the WHO declared the outbreak of SARS-CoV-2 as a public health
emergency. In the present study, we compared the preventative and therapeutic strategies and the success rates of Iran and Switzerland during the COVID-19 outbreak.
Materials and Methods: This study was conducted using electronic databases such as PubMed, Scopus, and
Web of Science. In addition, the official documents of developed countries and WHO from 1st February until 15th May 2020 were studied. Relevant documents were reviewed in detail, and vital data were extracted.
Results: Both countries have restriction policies to reduce the infection rate in the prevention setting. These
policies, such as the recommendation to all citizens to stay home unless necessary, army participation, and
non-face-to-face counseling, were surveyed by similar techniques in both countries. Some policies were
implemented in both countries with different protocols. These policies, including social distancing practices,
smart distancing methods, business activities, border closures, border controls, and restrictions, travel
restrictions, testing and screening for infection and fever, and decreased working hours, were performed in
both countries. In the treatment setting, the therapeutic strategy used in Iran consisted of hydroxychloroquine
or chloroquine phosphate and anti-viral drugs. Switzerland followed the guidelines of the European countries.
The infection rate, recovery rate, and death rate were 0.139%, 78.73%, and 5.91% in Iran, while these rates
were 0.352%, 88.81%, and 6.15% in Switzerland, respectively.
Conclusion: Due to the lack of special treatment for the disease, prevention must be considered the most
important factor in policymaking. Importantly, observing social distance is the most effective method among
the preventative strategies. The capacity of the health care systems to provide optimal services and facilities is
an important factor for patients recovery. |
| first_indexed | 2024-04-09T17:51:42Z |
| format | Article |
| id | doaj.art-9cd7e4aa464c4534b5f9c676ba7ad37a |
| institution | Directory Open Access Journal |
| issn | 2345-3907 |
| language | English |
| last_indexed | 2024-04-09T17:51:42Z |
| publishDate | 2022-12-01 |
| publisher | Shahid Beheshti University of Medical Sciences |
| record_format | Article |
| series | Novelty in Biomedicine |
| spelling | doaj.art-9cd7e4aa464c4534b5f9c676ba7ad37a2023-04-15T17:57:40ZengShahid Beheshti University of Medical SciencesNovelty in Biomedicine2345-39072022-12-0110421922510.22037/nbm.v10i4.3821538215Comparison between Management and Pharmacotherapy of COVID-19 in Iran and SwitzerlandPayam PeymaniSomaye BazdarLeila ZareiMehdi HoorangNazafarin Hatami-MazinaniKamran B LankaraniAli Reza SaliliFatemeh DehghaniFarshad BargrizanehSara MoghaddamMaryam MatouriShima JafariSeyyed Amirreza SaghiHamed DelamMotahareh Mahi-BirjandBackground: On 30 January 2020, the WHO declared the outbreak of SARS-CoV-2 as a public health emergency. In the present study, we compared the preventative and therapeutic strategies and the success rates of Iran and Switzerland during the COVID-19 outbreak. Materials and Methods: This study was conducted using electronic databases such as PubMed, Scopus, and Web of Science. In addition, the official documents of developed countries and WHO from 1st February until 15th May 2020 were studied. Relevant documents were reviewed in detail, and vital data were extracted. Results: Both countries have restriction policies to reduce the infection rate in the prevention setting. These policies, such as the recommendation to all citizens to stay home unless necessary, army participation, and non-face-to-face counseling, were surveyed by similar techniques in both countries. Some policies were implemented in both countries with different protocols. These policies, including social distancing practices, smart distancing methods, business activities, border closures, border controls, and restrictions, travel restrictions, testing and screening for infection and fever, and decreased working hours, were performed in both countries. In the treatment setting, the therapeutic strategy used in Iran consisted of hydroxychloroquine or chloroquine phosphate and anti-viral drugs. Switzerland followed the guidelines of the European countries. The infection rate, recovery rate, and death rate were 0.139%, 78.73%, and 5.91% in Iran, while these rates were 0.352%, 88.81%, and 6.15% in Switzerland, respectively. Conclusion: Due to the lack of special treatment for the disease, prevention must be considered the most important factor in policymaking. Importantly, observing social distance is the most effective method among the preventative strategies. The capacity of the health care systems to provide optimal services and facilities is an important factor for patients recovery.https://journals.sbmu.ac.ir/nbm/article/view/38215management and pharmacotherapy, covid-19, iran, switzerland |
| spellingShingle | Payam Peymani Somaye Bazdar Leila Zarei Mehdi Hoorang Nazafarin Hatami-Mazinani Kamran B Lankarani Ali Reza Salili Fatemeh Dehghani Farshad Bargrizaneh Sara Moghaddam Maryam Matouri Shima Jafari Seyyed Amirreza Saghi Hamed Delam Motahareh Mahi-Birjand Comparison between Management and Pharmacotherapy of COVID-19 in Iran and Switzerland Novelty in Biomedicine management and pharmacotherapy, covid-19, iran, switzerland |
| title | Comparison between Management and Pharmacotherapy of COVID-19 in Iran and Switzerland |
| title_full | Comparison between Management and Pharmacotherapy of COVID-19 in Iran and Switzerland |
| title_fullStr | Comparison between Management and Pharmacotherapy of COVID-19 in Iran and Switzerland |
| title_full_unstemmed | Comparison between Management and Pharmacotherapy of COVID-19 in Iran and Switzerland |
| title_short | Comparison between Management and Pharmacotherapy of COVID-19 in Iran and Switzerland |
| title_sort | comparison between management and pharmacotherapy of covid 19 in iran and switzerland |
| topic | management and pharmacotherapy, covid-19, iran, switzerland |
| url | https://journals.sbmu.ac.ir/nbm/article/view/38215 |
| work_keys_str_mv | AT payampeymani comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT somayebazdar comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT leilazarei comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT mehdihoorang comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT nazafarinhatamimazinani comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT kamranblankarani comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT alirezasalili comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT fatemehdehghani comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT farshadbargrizaneh comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT saramoghaddam comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT maryammatouri comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT shimajafari comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT seyyedamirrezasaghi comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT hameddelam comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland AT motaharehmahibirjand comparisonbetweenmanagementandpharmacotherapyofcovid19iniranandswitzerland |